Earnings Call Summary | Molina Healthcare(MOH.US) Q1 2024 Earnings Conference
Earnings Call Summary | Molina Healthcare(MOH.US) Q1 2024 Earnings Conference
The following is a summary of the Molina Healthcare, Inc. (MOH) Q1 2024 Earnings Call Transcript:
Financial Performance:
Molina Healthcare reported Q1 2024 adjusted earnings per share of $5.73 on $9.5 billion of premium revenue.
The company registered an 88.5% consolidated Medical Care Ratio (MCR), denoting competent medical cost management in all business segments.
Despite earnings guidance reporting a $0.30 component, the overall strength of the underlying business counterbalanced it.
Molina Healthcare's Q1 MCR for Medicaid was 89.7%, Medicare was at 88.7% and Marketplace stood at 73.3%.
Molina has reaffirmed its full-year 2024 guidance of $38 billion of premium revenue and a minimum of $23.50 in earnings per share.
Business Progress:
Over half a million members were added through expansion in California and a new health plan in Nebraska.
The company won a substantial RFP contract in Texas, retained a contract in Michigan, and has a robust growth pipeline with imminent opportunities in Kansas, Georgia, and North Carolina.
Application of mergers and acquisitions is viewed as a key growth strategy, manifested in the acquisition of Bright HealthCare.
Molina projects its Medicaid footprint to be a significant growth catalyst for dual-eligible membership following future CMS directives.
The company aims to yield a High Single Digit pre-tax margin by year-end, maintaining a target MCR range of 78% to 80% for the year.
Molina expects its Dual-eligible Special Needs Plan (D-SNP) business to be a major growth category.
The company anticipates significant growth by 2026 due to a combination of contract wins, M&A, and organic growth.
More details: Molina Healthcare IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
The following is a summary of the Molina Healthcare, Inc. (MOH) Q1 2024 Earnings Call Transcript:
以下是莫利納醫療保健公司(MOH)2024年第一季度業績電話會議記錄摘要:
Financial Performance:
財務業績:
Molina Healthcare reported Q1 2024 adjusted earnings per share of $5.73 on $9.5 billion of premium revenue.
The company registered an 88.5% consolidated Medical Care Ratio (MCR), denoting competent medical cost management in all business segments.
Despite earnings guidance reporting a $0.30 component, the overall strength of the underlying business counterbalanced it.
Molina Healthcare's Q1 MCR for Medicaid was 89.7%, Medicare was at 88.7% and Marketplace stood at 73.3%.
Molina has reaffirmed its full-year 2024 guidance of $38 billion of premium revenue and a minimum of $23.50 in earnings per share.
Molina Healthcare報告稱,2024年第一季度調整後的每股收益爲5.73美元,保費收入爲95億美元。
該公司的合併醫療保健比率(MCR)爲88.5%,這意味着所有業務領域都有良好的醫療成本管理。
儘管收益指引報告了0.30美元的組成部分,但基礎業務的整體實力抵消了這一點。
莫利納醫療第一季度醫療補助的MCR爲89.7%,醫療保險爲88.7%,Marketplace爲73.3%。
莫利納重申了其2024年全年保費收入380億美元的預期,每股收益至少爲23.50美元。
Business Progress:
業務進展:
Over half a million members were added through expansion in California and a new health plan in Nebraska.
The company won a substantial RFP contract in Texas, retained a contract in Michigan, and has a robust growth pipeline with imminent opportunities in Kansas, Georgia, and North Carolina.
Application of mergers and acquisitions is viewed as a key growth strategy, manifested in the acquisition of Bright HealthCare.
Molina projects its Medicaid footprint to be a significant growth catalyst for dual-eligible membership following future CMS directives.
The company aims to yield a High Single Digit pre-tax margin by year-end, maintaining a target MCR range of 78% to 80% for the year.
Molina expects its Dual-eligible Special Needs Plan (D-SNP) business to be a major growth category.
The company anticipates significant growth by 2026 due to a combination of contract wins, M&A, and organic growth.
通過加利福尼亞州的擴張和內布拉斯加州的新健康計劃,增加了超過50萬名會員。
該公司在德克薩斯州贏得了一份大量的RFP合同,在密歇根州保留了一份合同,並且在堪薩斯州、喬治亞州和北卡羅來納州擁有強勁的增長渠道,機會迫在眉睫。
併購的應用被視爲一項關鍵的增長戰略,對光明醫療的收購就體現了這一點。
根據未來的CMS指令,莫利納預計,其醫療補助足跡將成爲雙重資格成員的重要增長催化劑。
該公司的目標是到年底實現較高的個位數稅前利潤率,將該年度的目標MCR區間維持在78%至80%。
莫利納預計,其雙重資格特殊需求計劃(D-SNP)業務將成爲主要的增長類別。
該公司預計,由於合同中標、併購和有機增長相結合,到2026年將實現顯著增長。
More details: Molina Healthcare IR
更多詳情: 莫利納醫療保健 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧